New ESC 2023 Cardiomyopathy guidelines: Truths trail by 17 years!

It was 2006 Allow me to recount an unassuming piece of a PowerPoint presentation from my institute, Madras Medical College, at the annual Cardiological Society meeting in New Delhi. The paper was categorized under miscellaneous sessions. I vividly remember the day. I have to admit, It was a nearly empty hall E, located in the basement of Hotel Ashoka. After the talk, I looked up to find that neither the chairman nor the handful of kind academic souls had any questions or comments to make. Pausing for a few moments, I quietly walked down the podium with an inexplicable silent pain. The title of the presentation was “Non-dilated cardiomyopathy” non-dilated-cardiomyopathyDownload Welcome to ESC Congress Amsterdam August 2023 ESC, has come out with this new update on cardiomyopathy. It is a pleasant surprise to find the term “Non dilated cardiomyopathy” entered the cardiology academia, authenticated by the ESC. I must confess, it is difficult to conceal the joy and a little bit of self-pride. Some observations from this document 1. Despite our tremendous knowledge base, we are yet to hang up our boots in our pursuit of an Ideal cardiomyopathy definition. Genotypes or phenotypes? Phenotype is closer to reality, while genotype is largely imaginary. It looks like, The newer guidelines are moving towards a phenotype-based approach in all aspects except in risk prediction. Fair enough. 2. All cardiomyopathi...
Source: Dr.S.Venkatesan MD - Category: Cardiology Authors: Tags: cardiomyopathy Dilated cardiomyopathy hypertrophic cardiomyopathy ischemic cardiomyopathy Uncategorized drsvenkatesan ESC 2023 new cardiomyopathy guideline ndlvc non dilated cardiomyopathy Source Type: blogs